$570.15
+5.49(0.97%)
Mkt Cap $45.4B
$361.04
$766.68
52-Week Range
At a Glance
AI-generatedIDEXX Laboratories, Inc.
Revenue breakdown: CAG Diagnostics Recurring Revenue (28.6%), Product (20.7%), Service (15%).
8-K
IDEXX Laboratories, Inc. announced that Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, will cease her role effective April 13, 2026, and provide advisory services until July 13, 2026, under a Separation Agreement providing $2,286,000 in total separation benefits due to position elimination.$45.4B
Market Cap
$4.3B
Revenue
$1.1B
Net Income
Employees11,000
Fundamentals
How The Business Makes Money
Revenue by Segment
CAG Diagnostics Recurring Revenue28.6%($9.5B)
Product20.7%($6.9B)
Service15%($5.0B)
Reference Laboratory Diagnostic And Consulting Services12.2%($4.0B)
Vet Lab Consumables12%($4.0B)
Rapid Assay Products3.2%($1.1B)
Veterinary Software Services And Diagnostic Imaging Systems2.8%($938M)
Recurring Revenue2.2%($741M)
CAG Diagnostic Capital Instruments1.4%($470M)
CAG Diagnostics Service And Accessories1.2%($392M)
Systems And Hardware0.6%($197M)
Revenue by Geography
Americas35.4%($8.4B)
US32.4%($7.7B)
EMEA10.4%($2.5B)
Asia Pacific4.2%($996M)
Europethe Middle Eastand Africa Other2.5%($603M)
DE2.2%($530M)
CA2%($470M)
GB1.7%($411M)
Asia Pacific Other1.4%($339M)
FR1.4%($334M)
AU1.3%($310M)
Latin America And Caribbean1.1%($258M)
JP1%($232M)
ES0.8%($185M)
IT0.8%($179M)
CN0.5%($116M)
CH0.5%($114M)
NL0.4%($105M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0000874716
ISINUS45168D1046
CUSIP45168D104
Phone207 556 0300
AddressOne IDEXX Drive, Westbrook, ME, 04092, US
SEC EDGAR